These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24971311)

  • 1. Cardioprotective effects of osteopontin-1 during development of murine ischemic cardiomyopathy.
    Duerr GD; Mesenholl B; Heinemann JC; Zoerlein M; Huebener P; Schneider P; Feisst A; Ghanem A; Tiemann K; Dewald D; Welz A; Dewald O
    Biomed Res Int; 2014; 2014():124063. PubMed ID: 24971311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice.
    Duerr GD; Dewald D; Schmitz EJ; Verfuerth L; Keppel K; Peigney C; Ghanem A; Welz A; Dewald O
    Mediators Inflamm; 2016; 2016():7174127. PubMed ID: 27403038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte specific peroxisome proliferator-activated receptor-α overexpression leads to irreversible damage in ischemic murine heart.
    Duerr GD; Heinemann JC; Arnoldi V; Feisst A; Kley J; Ghanem A; Welz A; Dewald O
    Life Sci; 2014 May; 102(2):88-97. PubMed ID: 24657893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.
    Duerr GD; Heinemann JC; Suchan G; Kolobara E; Wenzel D; Geisen C; Matthey M; Passe-Tietjen K; Mahmud W; Ghanem A; Tiemann K; Alferink J; Burgdorf S; Buchalla R; Zimmer A; Lutz B; Welz A; Fleischmann BK; Dewald O
    Basic Res Cardiol; 2014 Jul; 109(4):425. PubMed ID: 24980781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of ischemic cardiomyopathy induced by repetitive ischemia and reperfusion.
    Dewald O; Frangogiannis NG; Zoerlein MP; Duerr GD; Taffet G; Michael LH; Welz A; Entman ML
    Thorac Cardiovasc Surg; 2004 Oct; 52(5):305-11. PubMed ID: 15470614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion.
    Kossmehl P; Schönberger J; Shakibaei M; Faramarzi S; Kurth E; Habighorst B; von Bauer R; Wehland M; Kreutz R; Infanger M; Schulze-Tanzil G; Paul M; Grimm D
    J Mol Med (Berl); 2005 Aug; 83(8):626-37. PubMed ID: 15770497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
    Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
    Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice.
    Duerr GD; Elhafi N; Bostani T; Ellinger J; Swieny L; Kolobara E; Welz A; Dewald O
    J Biomed Biotechnol; 2011; 2011():961298. PubMed ID: 21151617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
    Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
    Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production.
    Sawaki D; Czibik G; Pini M; Ternacle J; Suffee N; Mercedes R; Marcelin G; Surenaud M; Marcos E; Gual P; Clément K; Hue S; Adnot S; Hatem SN; Tsuchimochi I; Yoshimitsu T; Hénégar C; Derumeaux G
    Circulation; 2018 Aug; 138(8):809-822. PubMed ID: 29500246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction.
    Vilahur G; Juan-Babot O; Peña E; Oñate B; Casaní L; Badimon L
    J Mol Cell Cardiol; 2011 Mar; 50(3):522-33. PubMed ID: 21219908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG postconditioning after reperfused myocardial infarction is associated with modulated inflammation, less apoptosis, and better left ventricular function.
    Duerr GD; Wu S; Schneider ML; Marggraf V; Weisheit CK; Velten M; Verfuerth L; Frede S; Boehm O; Treede H; Dewald O; Baumgarten G; Kim SC
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H995-H1007. PubMed ID: 32857588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous osteopontin induces myocardial CCL5 and MMP-2 activation that contributes to inflammation and cardiac remodeling in a mouse model of chronic Chagas heart disease.
    Caballero EP; Santamaría MH; Corral RS
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):11-23. PubMed ID: 28987763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning.
    Wang Y; Chen B; Shen D; Xue S
    Heart Vessels; 2009 Mar; 24(2):116-23. PubMed ID: 19337795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
    López B; González A; Lindner D; Westermann D; Ravassa S; Beaumont J; Gallego I; Zudaire A; Brugnolaro C; Querejeta R; Larman M; Tschöpe C; Díez J
    Cardiovasc Res; 2013 Jul; 99(1):111-20. PubMed ID: 23619422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of adverse remodelling by osteopontin in a genetic heart failure model.
    Psarras S; Mavroidis M; Sanoudou D; Davos CH; Xanthou G; Varela AE; Panoutsakopoulou V; Capetanaki Y
    Eur Heart J; 2012 Aug; 33(15):1954-63. PubMed ID: 21525025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy.
    Renault MA; Robbesyn F; Réant P; Douin V; Daret D; Allières C; Belloc I; Couffinhal T; Arnal JF; Klingel K; Desgranges C; Dos Santos P; Charpentier F; Gadeau AP
    Circ Heart Fail; 2010 May; 3(3):431-9. PubMed ID: 20200330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta.
    Xie Z; Singh M; Siwik DA; Joyner WL; Singh K
    J Biol Chem; 2003 Dec; 278(49):48546-52. PubMed ID: 14500723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.